Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)

Mes dernières consult.
Top consultations
1758
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an international commercial-stage company focused on the ophthalmic market.

It seeks and evaluate commercial and late-stage ophthalmic products.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi611996Chairman & Chief Executive Officer
Philippe Masquida542012Executive Vice President & MD-European Operations
Sandrine Gestin481999Finance Director
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA652010Director
Birgit Stattin Norinder682011Director
Adrienne L. Graves, PhD612014Director
Luzi Andreas von Bidder632014Director
Lester J. Kaplan, PhD652014Director
Gavin M. Spencer, PhD452005Executive Vice President-Corporate Development
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 22 870 000 22 643 897 99.0% 0 0.0% 99.0%
Actionnaires
Nom Actions%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 514 3,45%
HBM Partners AG 325 000 1,42%
New Enterprise Associates LLC 283 094 1,24%
Michele Garufi 181 051 0,79%
OP Asset Management Ltd. 125 000 0,55%
Dimensional Fund Advisors LP 98 923 0,43%
Talence Gestion SAS 80 000 0,35%
Elizabeth Marie Robinson, PhD 74 060 0,32%
Lester J. Kaplan, PhD 69 131 0,30%
Nicox SA 50 903 0,22%
Participations
Nom Actions%Valorisation
Nicox (COX) 50 9030,22%547 593 USD
Secteur
Santé
Recherche pharmaceutique et médicale
 Produits pharmaceutiques
  Produits pharmaceutiques
   Pharmacies spécialisées et de pointe
Publicité
Secteur Pharmacies spécialisées et de pointe
Var. 1janvCapitalisation (M$)
NICOX SA-22.33%287
ABBVIE INC8.31%104 487
BIOGEN INC0.49%67 459
MERCK KGAA8.23%13 715
KYOWA HAKKO KIRIN CO L..-23.10%8 189
MALLINCKRODT PLC0.56%8 084
JAZZ PHARMACEUTICALS P..-10.19%7 641
ZHANGZHOU PIENTZEHUANG..5.76%4 371
YUHAN CORPORATION--.--%2 984
INDIVIOR PLC67.47%2 970
MAYNE PHARMA GROUP LTD37.23%2 140
THERAPEUTICSMD INC-35.10%1 352
ADVANCED ACCELERATOR A..--.--%1 346
SUPERNUS PHARMACEUTICA..62.72%1 083
NICHI-IKO PHARMACEUTIC..-38.58%1 049
REPLIGEN CORPORATION9.19%1 044
LG LIFE SCIENCES, LTD--.--%1 007
EAGLE PHARMACEUTICALS ..-31.25%953
KNIGHT THERAPEUTICS IN..10.91%865
DONG-A ST CO LTD--.--%795
RECIPHARM PUBL AB19.39%789
Secteur Pharmacies spécialisées et de pointe
NicOx SA : Connexions
The Clinical Research Institute of the Foundation
KeepYourSight Foundation
The Association for Research in Vision & Ophthalmology
Aciex Therapeutics, Inc.
Delife SRL
Wingfirm Pharma AB
Himalayan Cataract Project
Partners For Utvecklingsinvesteringar Inom Life Sciences AB
Navigation Dynamics AB
Keck Graduate Institute of Applied Life Sciences
Wntresearch AB
Encore Vision, Inc.
American Glaucoma Society
Pan-American Ophthalmological Foundation
Envisia Therapeutics, Inc.
Relivia SRL
American Academy of Ophthalmology, Inc.
Women in Ophthalmology
Ferring Holding SA
American Academy of Ophthalmology Foundation
Ferring International Center SA
The American Society of Cataract & Refractive Surgery
Neurotech Pharmaceuticals, Inc. (United States)
Glaucoma Research Foundation
Medinox, Inc.
Aerpio Therapeutics, Inc.
FFB Clinical Research Institute
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
© 2016 People , Fundamentals and Ownership